top of page
ABOUT
Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.
We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.
Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.
Our headquarter is based at Technopark Zurich, in the heart of Switzerland.
Curious to know more about what we do? Click below and listen to Hylomorph CEO, Dr. Simone Bottan.
TEAM
Credits: Lichtsteiner Foundation
BOARD OF DIRECTORS
AWARDS AND SUPPORT








Co-funded by the Horizon 2020 programme of the European Union
bottom of page